The Cognitive Impact of Antiepileptic Drugs

Overview

Journal Ther Adv Neurol Disord

Specialty Neurology

Date 2011 Dec 14

PMID 22164192

Citations 123

Authors

Clare M Eddy

Hugh E Rickards

Andrea E Cavanna

Affiliations

Soon will be listed here.

Abstract

Effective treatment of epilepsy depends on medication compliance across a lifetime, and studies indicate that drug tolerability is a significant limiting factor in medication maintenance. Available antiepileptic drugs (AEDs) have the potential to exert detrimental effects on cognitive function and therefore compromise patient wellbeing. On the other hand, some agents may serve to enhance cognitive function. In this review paper, we highlight the range of effects on cognition linked to a variety of newer and older AEDs, encompassing key alterations in both specific executive abilities and broader neuropsychological functions. Importantly, the data reviewed suggest that the effects exerted by an AED could vary depending on both patient characteristics and drug-related variables. However, there are considerable difficulties in evaluating the available evidence. Many studies have failed to investigate the influence of patient and treatment variables on cognitive functioning. Other difficulties include variation across studies in relation to design, treatment group and assessment tools, poor reporting of methodology and poor specification of the cognitive abilities assessed. Focused and rigorous experimental designs including a range of cognitive measures assessing more precisely defined abilities are needed to fill the gaps in our knowledge and follow up reported patterns in the literature. Longitudinal studies are needed to improve our understanding of the influence of factors such as age, tolerance and the stability of cognitive effects. Future trials comparing the effects of commonly prescribed agents across patient subgroups will offer critical insight into the role of patient characteristics in determining the cognitive impact of particular AEDs.

Citing Articles

Unraveling the neuroprotective effect of perampanel and lacosamide combination in the corneal kindling model for epilepsy in mice.

Tehreem S, Sabir A, Farooq M, Ashraf W, Alqahtani F, Ahmad T Animal Model Exp Med. 2025; 8(2):222-238.

PMID: 39846432 PMC: 11871093. DOI: 10.1002/ame2.12524.

Identification of circulating risk biomarkers for cognitive decline in a large community-based population in Chongqing China.

Kang Y, Feng Z, Zhang Q, Liu M, Li Y, Yang H Alzheimers Dement. 2024; 21(2):e14443.

PMID: 39713874 PMC: 11848162. DOI: 10.1002/alz.14443.

Phytocannabinoids restore seizure-induced alterations in emotional behaviour in male rats.

Gom R, Wickramarachchi P, George A, Lightfoot S, Newton-Gunderson D, Hill M Neuropsychopharmacology. 2024; .

PMID: 39433952 DOI: 10.1038/s41386-024-02005-y.

Unraveling the shared genetics of common epilepsies and general cognitive ability.

Karadag N, Hagen E, Shadrin A, van der Meer D, OConnell K, Rahman Z Seizure. 2024; 122:105-112.

PMID: 39388989 PMC: 11681332. DOI: 10.1016/j.seizure.2024.09.016.

Sleeping High and Getting Lost on the Spiky Road: What Affects Visual Memory in Older Adults With Epilepsy, and What Can We Do About It?.

Marawar R Epilepsy Curr. 2024; 24(2):114-116.

PMID: 39280061 PMC: 11394408. DOI: 10.1177/15357597241234246.

References

Sun W, Wang Y, Wang W, Wu X . Attention changes in epilepsy patients following 3-month topiramate or valproate treatment revealed by event-related potential. Int J Psychophysiol. 2008; 68(3):235-41. DOI: 10.1016/j.ijpsycho.2008.02.003. View

Smith D, Baker G, Davies G, Dewey M, Chadwick D . Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia. 1993; 34(2):312-22. DOI: 10.1111/j.1528-1157.1993.tb02417.x. View

Glauser T, Cnaan A, Shinnar S, Hirtz D, Dlugos D, Masur D . Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med. 2010; 362(9):790-9. PMC: 2924476. DOI: 10.1056/NEJMoa0902014. View

Meador K, Loring D, Hulihan J, Kamin M, Karim R . Differential cognitive and behavioral effects of topiramate and valproate. Neurology. 2003; 60(9):1483-8. DOI: 10.1212/01.wnl.0000063308.22506.19. View

Mula M, Trimble M, Thompson P, Sander J . Topiramate and word-finding difficulties in patients with epilepsy. Neurology. 2003; 60(7):1104-7. DOI: 10.1212/01.wnl.0000056637.37509.c6. View

Piazzini A, Chifari R, Canevini M, Turner K, Fontana S, Canger R . Levetiracetam: an improvement of attention and of oral fluency in patients with partial epilepsy. Epilepsy Res. 2005; 68(3):181-8. DOI: 10.1016/j.eplepsyres.2005.10.006. View

Camposano S, Major P, Halpern E, Thiele E . Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile. Epilepsia. 2008; 49(7):1186-91. DOI: 10.1111/j.1528-1167.2008.01589.x. View

Majkowski J, Neto W, Wapenaar R, Oene J . Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine. Epilepsia. 2005; 46(5):648-53. DOI: 10.1111/j.1528-1167.2005.35904.x. View

Seidel W, Mitchell W . Cognitive and behavioral effects of carbamazepine in children: data from benign rolandic epilepsy. J Child Neurol. 1999; 14(11):716-23. DOI: 10.1177/088307389901401106. View

10.

Berent S, Sackellares J, Giordani B, Wagner J, Donofrio P, Abou-Khalil B . Zonisamide (CI-912) and cognition: results from preliminary study. Epilepsia. 1987; 28(1):61-7. DOI: 10.1111/j.1528-1157.1987.tb03624.x. View

11.

Lee H, Jung D, Suh C, Kwon S, Park S . Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up. Epilepsy Behav. 2006; 8(4):736-41. DOI: 10.1016/j.yebeh.2006.03.006. View

12.

Shehata G, Bateh A, Hamed S, Rageh T, Elsorogy Y . Neuropsychological effects of antiepileptic drugs (carbamazepine versus valproate) in adult males with epilepsy. Neuropsychiatr Dis Treat. 2009; 5:527-33. PMC: 2773283. DOI: 10.2147/ndt.s5903. View

13.

Hessen E, Lossius M, Gjerstad L . Antiepileptic monotherapy significantly impairs normative scores on common tests of executive functions. Acta Neurol Scand. 2008; 119(3):194-8. DOI: 10.1111/j.1600-0404.2008.01109.x. View

14.

Riva D, Devoti M . Discontinuation of phenobarbital in children: effects on neurocognitive behavior. Pediatr Neurol. 1996; 14(1):36-40. DOI: 10.1016/0887-8994(95)00224-3. View

15.

Aikia M, Jutila L, Salmenpera T, Mervaala E, Kalviainen R . Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy. Epilepsy Behav. 2006; 8(4):750-5. DOI: 10.1016/j.yebeh.2006.03.007. View

16.

Engelberts N, Klein M, van der Ploeg H, Heimans J, Jolles J, Kasteleijn-Nolst Trenite D . Cognition and health-related quality of life in chronic well-controlled patients with partial epilepsy on carbamazepine monotherapy. Epilepsy Behav. 2003; 3(4):316-321. DOI: 10.1016/s1525-5050(02)00036-7. View

17.

McKee P, Blacklaw J, Butler E, Gillham R, Brodie M . Variability and clinical relevance of the interaction between sodium valproate and carbamazepine in epileptic patients. Epilepsy Res. 1992; 11(3):193-8. DOI: 10.1016/0920-1211(92)90098-e. View

18.

Mula M, Trimble M, Sander J . The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy. Epilepsia. 2003; 44(12):1573-7. DOI: 10.1111/j.0013-9580.2003.19103.x. View

19.

Donati F, Gobbi G, Campistol J, Rapatz G, Daehler M, Sturm Y . Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology. 2006; 67(4):679-82. DOI: 10.1212/01.wnl.0000230138.46508.5b. View

20.

Arroyo S, Anhut H, Kugler A, Lee C, Knapp L, Garofalo E . Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia. 2003; 45(1):20-7. DOI: 10.1111/j.0013-9580.2004.31203.x. View